SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Philip C. Robinson, Simon Horsburgh, Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities, Maturitas, 2014, 78, 4, 245

    CrossRef

  2. 2
    Lisa K. Stamp, Safety profile of anti-gout agents, Current Opinion in Rheumatology, 2014, 26, 2, 162

    CrossRef

  3. 3
    Sheena N. Ramasamy, Cameron S. Korb-Wells, Diluk R. W. Kannangara, Myles W. H. Smith, Nan Wang, Darren M. Roberts, Garry G. Graham, Kenneth M. Williams, Richard O. Day, Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012, Drug Safety, 2013, 36, 10, 953

    CrossRef

  4. 4
    Xin-Xue Li, Mei Han, Yu-Yi Wang, Jian-Ping Liu, Chinese herbal medicine for gout: a systematic review of randomized clinical trials, Clinical Rheumatology, 2013, 32, 7, 943

    CrossRef

  5. 5
    L. R. Harrold, K. M. Mazor, A. Negron, J. Ogarek, C. Firneno, R. A. Yood, Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire, Rheumatology, 2013, 52, 9, 1623

    CrossRef

  6. 6
    Gil Y. Melmed, Corey Allan Siegel, Brennan M. Spiegel, John I. Allen, Robert Cima, Jean-Frederic Colombel, Themistocles Dassopoulos, Lee A. Denson, Sharon Dudley-Brown, Andrew Garb, Stephen B. Hanauer, Michael D. Kappelman, James D. Lewis, Isabelle Lynch, Amy Moynihan, David T. Rubin, R. Balfour Sartor, Ronald M. Schwartz, Douglas C. Wolf, Thomas A. Ullman, Quality Indicators for Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2013, 19, 3, 662

    CrossRef

  7. 7
    G. Zandman-Goddard, H. Amital, N. Shamrayevsky, R. Raz, V. Shalev, G. Chodick, Rates of adherence and persistence with allopurinol therapy among gout patients in Israel, Rheumatology, 2013, 52, 6, 1126

    CrossRef

  8. 8
    Eswar Krishnan, Linjun Chen, Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009, Arthritis Research & Therapy, 2013, 15, 6, R181

    CrossRef

  9. 9
    Ted R. Mikuls, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  10. 10
    Dinesh Khanna, Puja P. Khanna, John D. Fitzgerald, Manjit K. Singh, Sangmee Bae, Tuhina Neogi, Michael H. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez-Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A. Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A. Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E. Furst, N. Lawrence Edwards, Brian Mandell, H. Ralph Schumacher, Mark Robbins, Neil Wenger, Robert Terkeltaub, 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis, Arthritis Care & Research, 2012, 64, 10
  11. 11
    Jasvinder A Singh, Can racial disparities in optimal gout treatment be reduced? evidence from a randomized trial, BMC Medicine, 2012, 10, 1, 15

    CrossRef

  12. 12
    Lisa K. Stamp, William J. Taylor, Peter B. Jones, Jo L. Dockerty, Jill Drake, Christopher Frampton, Nicola Dalbeth, Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol, Arthritis & Rheumatism, 2012, 64, 8
  13. 13
    Naomi Schlesinger, Treatment of Chronic Gouty Arthritis: It Is Not Just About Urate-Lowering Therapy, Seminars in Arthritis and Rheumatism, 2012, 42, 2, 155

    CrossRef

  14. 14
    Frédéric Lioté, Robert Terkeltaub, Gout & Other Crystal Arthropathies, 2012,

    CrossRef

  15. 15
    Jasvinder A. Singh, Supriya G. Reddy, Gout & Other Crystal Arthropathies, 2012,

    CrossRef

  16. 16
    Fernando Perez-Ruiz, Loreto Carmona, Maria Jesús García Yébenes, Eliseo Pascual, Eugenio de Miguel, Inmaculada Ureña, Miguel A. González-Gay, An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting, Journal of Clinical Rheumatology, 2011, 17, 7, 349

    CrossRef

  17. 17
    Tuhina Neogi, Gout, New England Journal of Medicine, 2011, 364, 5, 443

    CrossRef

  18. 18
    Prachaya Nitichaikulvatana, Katherine S. Upchurch, Leslie R. Harrold, Impact of Deficits in Gout Care on Hospitalizations, Journal of Clinical Rheumatology, 2011, 17, 7, 389

    CrossRef

  19. 19
    Gérard Reach, L’observance dans la goutte, Revue du Rhumatisme, 2011, 78, 4, 319

    CrossRef

  20. 20
    IZAYA NAKAYA, TAMEHACHI NAMIKOSHI, YUKI TSURUTA, TAKESHI NAKATA, YUGO SHIBAGAKI, YOSHIHIRO ONISHI, SHUNICHI FUKUHARA, Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: A questionnaire survey, Nephrology, 2011, 16, 5
  21. 21
    Raj Nair, Rohit Aggarwal, Dinesh Khanna, Methods of Formal Consensus in Classification/Diagnostic Criteria and Guideline Development, Seminars in Arthritis and Rheumatism, 2011, 41, 2, 95

    CrossRef

  22. 22
    N. Lawrence Edwards, Quality of Care in Patients with Gout: Why is Management Suboptimal and What Can Be Done About It?, Current Rheumatology Reports, 2011, 13, 2, 154

    CrossRef

  23. 23
    Bhavik J. Pandya, Aylin A. Riedel, Jason P. Swindle, Laura K. Becker, Ali Hariri, Omar Dabbous, Eswar Krishnan, Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings, Current Medical Research and Opinion, 2011, 27, 4, 737

    CrossRef

  24. 24
    Eliseo Pascual, Francisca Sivera, Mariano Andrés, Synovial fluid analysis for crystals, Current Opinion in Rheumatology, 2011, 1

    CrossRef

  25. 25
    JoAnn Zell Gillis, Pantelis Panopalis, Gabriela Schmajuk, Rosalind Ramsey-Goldman, Jinoos Yazdany, Systematic review of the literature informing the systemic lupus erythematosus indicators project: Reproductive health care quality indicators, Arthritis Care & Research, 2011, 63, 1
  26. 26
    Lisa K. Stamp, Sarah Jordan, The Challenges of Gout Management in the Elderly, Drugs & Aging, 2011, 28, 8, 591

    CrossRef

  27. 27
    Peter Gow, Treating gout in patients with comorbidities, International Journal of Clinical Rheumatology, 2011, 6, 6, 625

    CrossRef

  28. 28
    Gérard Reach, Treatment adherence in patients with gout, Joint Bone Spine, 2011, 78, 5, 456

    CrossRef

  29. 29
    Lisa K. Stamp, John L. O'Donnell, Mei Zhang, Jill James, Christopher Frampton, Murray L. Barclay, Peter T. Chapman, Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment, Arthritis & Rheumatism, 2011, 63, 2
  30. 30
    Jasvinder A. Singh, Michael D. Alpert, Gail Kerr, A national survey of Veterans Affairs Rheumatologists for relevance of quality of care indicators for Gout management, Arthritis Care & Research, 2010, 62, 9
  31. 31
    Geoffrey C. Wall, Carrie F. Koenigsfeld, Karly A. Hegge, Michelle M. Bottenberg, Adherence to treatment guidelines in two primary care populations with gout, Rheumatology International, 2010, 30, 6, 749

    CrossRef

  32. 32
    Brian T Fay, Ted R Mikuls, Advances and unmet needs in gout, International Journal of Clinical Rheumatology, 2010, 5, 2, 187

    CrossRef

  33. 33
    Corey A. Siegel, Gil Y. Melmed, Thomas A. Ullman, Improving quality of care in IBD: A STEEEP challenge, Inflammatory Bowel Diseases, 2010, 16, 1
  34. 34
    Leslie R. Harrold, Susan E. Andrade, Becky Briesacher, Marsha A. Raebel, Hassan Fouayzi, Robert A. Yood, Ira S. Ockene, The Dynamics of Chronic Gout Treatment: Medication Gaps and Return to Therapy, The American Journal of Medicine, 2010, 123, 1, 54

    CrossRef

  35. 35
    A. Pena, S. S. Virk, R. M. Shewchuk, J. J. Allison, O. Dale Williams, C. I. Kiefe, Validity versus feasibility for quality of care indicators: expert panel results from the MI-Plus study, International Journal for Quality in Health Care, 2010, 22, 3, 201

    CrossRef

  36. 36
    Jinoos Yazdany, Pantelis Panopalis, Joann Zell Gillis, Gabriela Schmajuk, Catherine H. MacLean, David Wofsy, Edward Yelin, A quality indicator set for systemic lupus erythematosus, Arthritis Care & Research, 2009, 61, 3
  37. 37
    Eliseo Pascual, Francisca Sivera, Gout: new advances in the diagnosis and management of an old disease, International Journal of Clinical Rheumatology, 2009, 4, 2, 203

    CrossRef

  38. 38
    Jasvinder A. Singh, Quality of life and quality of care for patients with gout, Current Rheumatology Reports, 2009, 11, 2, 154

    CrossRef

  39. 39
    Robin K. Dore, Gout, JCR: Journal of Clinical Rheumatology, 2008, 14, Supplement, S47

    CrossRef

  40. 40
    YEWON CHUNG, SOPHIE L. STOCKER, GARRY G. GRAHAM, RICHARD O. DAY, Optimizing Therapy With Allopurinol: Factors Limiting Hypouricemic Efficacy, The American Journal of the Medical Sciences, 2008, 335, 3, 219

    CrossRef

  41. 41
    Jinoos Yazdany, Catherine H MacLean, Quality of care in the rheumatic diseases: current status and future directions, Current Opinion in Rheumatology, 2008, 20, 2, 159

    CrossRef

  42. 42
    Michael A Becker, Saima Chohan, We can make gout management more successful now, Current Opinion in Internal Medicine, 2008, 7, 3, 308

    CrossRef

  43. 43
    Michael A Becker, Saima Chohan, We can make gout management more successful now, Current Opinion in Rheumatology, 2008, 20, 2, 167

    CrossRef

  44. 44
    William E. Braun, Therapy in Nephrology & Hypertension, 2008,

    CrossRef

  45. 45
    Nicola Dalbeth, Lisa Stamp, Allopurinol Dosing in Renal Impairment: Walking the Tightrope Between Adequate Urate Lowering and Adverse Events, Seminars in Dialysis, 2007, 20, 5
  46. 46
    Alberto Alonso Ruiz, Javier Vidal Fuentes, Jesús Tornero Molina, Jordi Carbonell Abelló, Pablo Lázaro y de Mercado, M. Dolores Aguilar Conesa, Asistance Quality Standards in Rheumatology, Reumatología Clínica (English Edition), 2007, 3, 5, 218

    CrossRef

  47. 47
    Naohiko Anzai, Hitoshi Endou, Drug discovery for hyperuricemia, Expert Opinion on Drug Discovery, 2007, 2, 9, 1251

    CrossRef

  48. 48
    L. K. Stamp, J. L. O’Donnell, P. T Chapman, Emerging therapies in the long-term management of hyperuricaemia and gout, Internal Medicine Journal, 2007, 37, 4
  49. 49
    Alberto Alonso Ruiz, Javier Vidal Fuentes, Jesús Tornero Molina, Jordi Carbonell Abelló, Pablo Lázaro, de Mercado, M. Dolores Aguilar Conesa, Estándares de calidad asistencial en reumatología, Reumatología Clínica, 2007, 3, 5, 218

    CrossRef

  50. 50
    Karl T Hoskison, Robert L Wortmann, Management of Gout in Older Adults, Drugs & Aging, 2007, 24, 1, 21

    CrossRef

  51. 51
    Jasvinder A. Singh, James S. Hodges, John P. Toscano, Steven M. Asch, Quality of care for gout in the US needs improvement, Arthritis Care & Research, 2007, 57, 5
  52. 52
    Eliseo Pascual, Francisca Sivera, Therapeutic advances in gout, Current Opinion in Rheumatology, 2007, 19, 2, 122

    CrossRef

  53. 53
    John S. Sundy, Michael S. Hershfield, Uricase and other novel agents for the management of patients with treatment-failure gout, Current Rheumatology Reports, 2007, 9, 3, 258

    CrossRef

  54. 54
    Chaitanya A. Sarawate, Kathleen K. Brewer, Wenya Yang, Pankaj A. Patel, H. Ralph Schumacher, Kenneth G. Saag, Alan W. Bakst, Gout Medication Treatment Patterns and Adherence to Standards of Care From a Managed Care Perspective, Mayo Clinic Proceedings, 2006, 81, 7, 925

    CrossRef

  55. 55
    Vibeke Strand, Measuring Quality in Arthritis Care: The Arthritis Foundation’s Quality Indicator Set for Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism, 2006, 35, 4, 205

    CrossRef

  56. 56
    Ted R Mikuls, Kenneth G Saag, New insights into gout epidemiology, Current Opinion in Rheumatology, 2006, 18, 2, 199

    CrossRef

  57. 57
    H. Ralph Schumacher, Lan X. Chen, Newer Therapeutic Approaches: Gout, Rheumatic Disease Clinics of North America, 2006, 32, 1, 235

    CrossRef

  58. 58
    Gim Gee Teng, Raj Nair, Kenneth G Saag, Pathophysiology, Clinical Presentation and Treatment of Gout, Drugs, 2006, 66, 12, 1547

    CrossRef

  59. 59
    Adel Fam, Crystal-Induced Arthropathies, 2006,

    CrossRef

  60. 60
    Fernando Perez-Ruiz, I??aki Hernando, Irama Villar, Joan M. Nolla, Correction of Allopurinol Dosing Should Be Based on Clearance of Creatinine, but Not Plasma Creatinine Levels, JCR: Journal of Clinical Rheumatology, 2005, 11, 3, 129

    CrossRef

  61. 61
    Laura L Krishnan, Maria E Suarez-Almazor, Evidence-based rheumatology practice, Current Opinion in Internal Medicine, 2005, 4, 3, 317

    CrossRef

  62. 62
    Larry W. Moreland, Febuxostat — Treatment for Hyperuricemia and Gout?, New England Journal of Medicine, 2005, 353, 23, 2505

    CrossRef

  63. 63
    Ted R. Mikuls, Kenneth G. Saag, Gout treatment: What is evidence-based and how do we determine and promote optimized clinical care?, Current Rheumatology Reports, 2005, 7, 3, 242

    CrossRef

  64. 64
    Robert L Wortmann, Recent advances in the management of gout and hyperuricemia, Current Opinion in Rheumatology, 2005, 17, 3, 319

    CrossRef

  65. 65
    F. Pérez-Ruiz, Tratamiento hipouricemiante en la gota: mitos y evidencias, Reumatología Clínica, 2005, 1, 3, 139

    CrossRef

  66. 66
    Jeffry D. Bieber, Robert A. Terkeltaub, Gout: On the brink of novel therapeutic options for an ancient disease, Arthritis & Rheumatism, 2004, 50, 8